STRO GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Sutro Biopharma Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
STROUDS INC
Did you know?
Holds 3.8x more cash than debt — a strong balance sheet.
Current Price
—
GoodMoat Value
$58.24
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Sutro Biopharma Inc (STRO) Quality Analysis
STRO Profitability
Profitability trend analysis coming soon
STRO Growth
Growth trend analysis coming soon
STRO Financial Health
Financial health indicators coming soon
STRO Quality & Fundamental Analysis
Sutro Biopharma Inc (STRO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Sutro Biopharma Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Sutro Biopharma Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency..
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Sutro Biopharma Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.